Study suggests age divide in cost-effectiveness of IVF treatment options
April 12, 2011 in Medical research
(PhysOrg.com) -- The findings of a study led by the University of Aberdeen could put IVF treatment 'on a more equal footing' with chronic diseases when it comes to making decisions about the cost effectiveness of treatment options.
The team, which included researchers from the University of Oxford, NHS Glasgow, Birmingham Womens Fertility Centre, and Aberdeen Maternity Hospital, used data from 6135 women from three Scottish Centres to model the costs and consequences of single and double embryo transfer in women of different ages.
The results indicate that single embryo transfer is likely to be preferred in most women under 37. However in older women who have a lower chance of pregnancy, including twin pregnancy, double embryo transfer may be considered cost-effective.
The team also conducted an analysis to assess how cost-effectiveness would change if women were to be allowed access to publicly funded treatment aged 40 years and above the current cut off point for IVF treatment on the NHS.
The Human Embryology and Fertilisation Authority (HEFA) which regulates IVF in the UK advocates the use of single embryo transfer as a way of reducing twin births associated with IVF and recommends a national target of a twin birth rate below 10 per cent.
Twin pregnancies are associated with increased maternal and neonatal complications, as well as long-term child disability, and the additional care required increases costs to the health service.
However, women are often deterred from taking up single embryo transfer fearing it will reduce their chances of conceiving or result in the need for additional treatment cycles.
The authors of the study, published in the British Journal for Obstetrics and Gynaecology, hope their findings will be considered by policy makers when it comes to making decisions about IVF treatment options.
Mr Graham Scotland, from the University of Aberdeen Health Economics Research Unit, led the study. He said: No other economic analysis has looked at a strategy of single versus double embryo transfer over multiple cycles in women of different ages. Our results generally support a strategy of single embryo transfer in women aged 36 or under, but as women get older the additional cost per extra live birth with double embryo transfer decreases.
No guidance exists on how much society should be willing to pay for a successful birth so we estimated the impact of the alternative numbers of embryos transferred on womens quality of life using quality-adjusted life years (QALYs), an approach which is used to assess the value for money of interventions in other areas of health care.
The researchers found that the additional cost per extra QALY for double versus single embryo transfer decreased with womens age because of the lower probability of twin pregnancy and associated complications with double embryo transfer in older women.
Under NICE guidelines in the UK, interventions that cost below £20,000 to £30,000 per additional QALY are often considered cost-effective.
Mr Scotland added: Applying this threshold range, single embryo transfer would be more likely to be considered cost-effective for women under 37 years.
For women aged 3739 years, the decision over embryo transfer may best be considered on a case-by-case basis, though our model suggests that double embryo transfer will have a higher likelihood of being considered cost-effective for older women within in this age range.
For women aged 40 and over double embryo transfer may offer the most efficient approach to IVF.
-
Elective single embryo transfer boosts the chance of a healthy baby
Dec 22, 2010 |
not rated yet |
0
-
Single embryo implants work better: study
Mar 25, 2009 |
not rated yet |
0
-
New strategy could reduce twin rate after IVF
Sep 30, 2010 |
not rated yet |
0
-
3 IVF attempts double chances
Nov 09, 2009 |
not rated yet |
0
-
Size of a woman's uterus can predict whether she is at risk of having very premature twins after IVF
Jul 09, 2008 |
not rated yet |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (3) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (41) |
45
-
Your brain on dye: Imaging neuronal voltage with fluorescent sensors and molecular wires
Feb 24, 2012 |
4.9 / 5 (9) |
0
-
Understanding the mechanisms of disease .
May 14, 2012
-
Short burst of hypersensitivity disorder?
May 13, 2012
-
Copper aspirinate
May 12, 2012
-
Ultraviolet rays and diseases
May 12, 2012
-
Article: Robot Reveals the Inner Workings of Brain Cells
May 11, 2012
-
Recommend to me the textbook on an inflammation, please
May 08, 2012
- More from Physics Forums - Medical Sciences
More news stories
Brain injury to soldiers can arise from exposure to a single explosion: study
A team of investigators have shown evidence of chronic traumatic encephalopathy (CTE) in brain tissue from blast-exposed military service personnel.
Medical research
8 hours ago |
not rated yet |
0
|
Paralyzed individuals control robotic arms to reach and grasp using brain computer interface (w/ Video)
In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own for the first time in nearly 15 years by using her thoughts to direct a robotic arm. The ...
Medical research
9 hours ago |
4.8 / 5 (6) |
0
|
How blind can 'read' shown in new research
A method developed at the Hebrew University of Jerusalem for training blind persons to "see" through the use of a sensory substitution device (SSD) has enabled those using the system to actually "read" an ...
Medical research
10 hours ago |
not rated yet |
0
Breaking down how we breathe
(Medical Xpress) -- If youre an average person (not from Lake Wobegon) you breathe in about 900 times an hour. You probably dont think about it much, but Daniel Mulkey does. He studies what ...
Medical research
12 hours ago |
not rated yet |
0
An international treaty is needed to improve medical research worldwide
An international treaty is a promising tool for improving the coherence, fairness, efficiency, and sustainability of the global health research and development system according to international experts writing in this week's ...
Medical research
May 15, 2012 |
not rated yet |
0
Zebrafish study isolates gene related to autism, schizophrenia and obesity
What can a fish tell us about human brain development? Researchers at Duke University Medical Center transplanted a set of human genes into a zebrafish and then used it to identify genes responsible for head ...
ApoE4 Alzheimer's gene causes brain's blood vessels to leak, die
Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National ...
Experts say psychiatry's diagnostic manual needs overhaul
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two ...
Study finds common antibiotic azithromycin carries heart risk
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...
Landscape of cancer genes and mutational processes in breast cancer
In a study published today in Nature, researchers describe nine new genes that drive the development of breast cancer. This takes the tally of all genes associated with breast cancer development to 40.
In drug-approval race, US FDA ahead of Canada, Europe
The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters ...